Author Prat, Alexandre

• 2013 | Review
  ​ ​Therapeutic Decisions in Multiple Sclerosis Moving Beyond Efficacy​
  Brueck, W.; Gold, R.; Lund, B. T.; Oreja-Guevara, C.; Prat, A.; Spencer, C. M.& Steinman, L. et al.​ (2013)
  JAMA Neurology, 70​(10) pp. 1315​-1324​.​
  Amer Medical Assoc. DOI: https://doi.org/10.1001/jamaneurol.2013.3510 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Conference Abstract
  ​ ​Fatal rebound MS activity following natalizumab withdrawal: ante and post-mortem immunological characterization of CNS-infiltrating cells​
  Larochelle, C.; Metz, I.; Lecuyer, M.-A.; Terouz, S.; Arbour, N.; Brueck, W. & Prat, A.​ (2015)
  Multiple Sclerosis Journal, 21 pp. 297​-298. ​31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)​, Barcelona, SPAIN.
  London​: Sage Publications Ltd.
  ​Details  WoS 

• 2017 | Journal Article
  ​ ​An updated histological classification system for multiple sclerosis lesions​
  Kuhlmann, T.; Ludwin, S.; Prat, A.; Antel, J. P.; Brueck, W. & Lassmann, H.​ (2017) 
  Acta Neuropathologica, 133(1) pp. 13​-24​.​ DOI: https://doi.org/10.1007/s00401-016-1653-y 
  ​Details  DOI  PMID  PMC  WoS 

• 2017 | Journal Article
  ​ ​Laquinimod enhances central nervous system barrier functions​
  Luehder, F.; Kebir, H.; Odoardi, F. ; Litke, T.; Sonneck, M. ; Alvarez, J. I. & Winchenbach, J. et al.​ (2017) 
  Neurobiology of Disease, 102 pp. 60​-69​.​ DOI: https://doi.org/10.1016/j.nbd.2017.02.002 
  ​Details  DOI  PMID  PMC  WoS 

• 2017 | Journal Article
  ​ ​Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal​
  Larochelle, C.; Metz, I.; Lecuyer, M.-A. ; Terouz, S.; Roger, M.; Arbour, N. & Brueck, W. et al.​ (2017) 
  Multiple Sclerosis Journal, 23(1) pp. 72​-81​.​ DOI: https://doi.org/10.1177/1352458516641775 
  ​Details  DOI  PMID  PMC  WoS 

• 2019 | Journal Article | 
  ​ ​IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening​
  Puscas, I.; Bernard-Patrzynski, F.; Jutras, M.; Lécuyer, M.-A. ; Bourbonnière, L.; Prat, A. & Leclair, G. et al.​ (2019) 
  Pharmaceutics, 11(11) pp. 587​.​ DOI: https://doi.org/10.3390/pharmaceutics11110587 
  ​Details  DOI 

• 2019 | Journal Article | 
  ​ ​Isolation of endothelial cells, pericytes and astrocytes from mouse brain​
  Bernard-Patrzynski, F.; Lécuyer, M.-A. ; Puscas, I.; Boukhatem, I.; Charabati, M.; Bourbonnière, L. & Ramassamy, C. et al.​ (2019) 
  PLoS One, 14(12) art. e0226302​.​ DOI: https://doi.org/10.1371/journal.pone.0226302 
  ​Details  DOI  PMID  PMC 

• 2019 | Journal Article
  ​ ​MicroRNA-223 protects neurons from degeneration in experimental autoimmune encephalomyelitis​
  Morquette, B.; Juźwik, C. A; Drake, S. S; Charabati, M.; Zhang, Y.; Lécuyer, M.-A.   & Galloway, D. A et al.​ (2019) 
  Brain: A Journal of Neurology, 142(10) pp. 2979-2995​-2995​.​ DOI: https://doi.org/10.1093/brain/awz245 
  ​Details  DOI  PMID  PMC 

• 2020 | Journal Article | Erratum | 
  ​ ​Erratum: Puscas, I.; et al. IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening. Pharmaceutics 2019, 11, 587​
  Puscas, I.; Bernard-Patrzynski, F.; Jutras, M.; Lécuyer, M.-A. ; Bourbonnière, L.; Prat, A. & Leclair, G. et al.​ (2020) 
  Pharmaceutics, 12(6) pp. 514​.​ DOI: https://doi.org/10.3390/pharmaceutics12060514 
  ​Details  DOI 

• 2022 | Journal Article
  ​ ​DICAM promotes T H 17 lymphocyte trafficking across the blood-brain barrier during autoimmune neuroinflammation​
  Charabati, M.; Grasmuck, C.; Ghannam, S.; Bourbonnière, L.; Fournier, A. P.; Lécuyer, M.-A. & Tastet, O. et al.​ (2022) 
  Science Translational Medicine, 14(626).​ DOI: https://doi.org/10.1126/scitranslmed.abj0473 
  ​Details  DOI 

Researcher

Sort

Items per Page